Agency Rule Review Plan
Texas Real Estate Commission
Title 22, Part 23
TRD-200600819
Filed: February 15, 2006
Texas Department of Licensing and Regulation
Title 16, Part 4
The Texas Department of Licensing and Regulation (Department) readopts
the administrative rules of 16 TAC Chapter 71, Warrantors of Vehicle Protection
Products in accordance with the Texas Government Code, §2001.039. The
Notice of Intent to Review was published in the December 23, 2005, issue of
the
Texas Register
(30 TexReg 8707).
In accordance with the requirements of Texas Government Code, §2001.039,
the Department reviewed the administrative rules of TAC Chapter 71, Warrantors
of Vehicle Protection Products to determine if the rules were obsolete, reflected
current legal and policy considerations, and reflected current procedures
of the Department.
The Department’s review has determined that the reasons for initially
adopting the rules continue to exist. The rules are still essential in implementing
the provisions of the Texas Occupations Code, Chapter 51 and 2306. Based on
the Department’s review, however, the Department proposes that amendments
be made which may be helpful in clarifying statutory and administrative rule
requirements and bring them more in line with current law and Department procedure.
Proposed changes will be published in the Proposed Rule Section of the
The Notice of Intent to Review was distributed to persons internal and
external to the agency. The public comment period closed January 23, 2006.
No public comments were received.
The rules are re-adopted in accordance with Texas Government Code, §2001.039.
This concludes the review of 16 TAC Chapter 71.
TRD-200600676
William H. Kuntz, Jr.
Executive Director
Texas Department of Licensing and Regulation
Filed: February 9, 2006
Title 22, Part 15
The Texas State Board of Pharmacy adopts the review of Chapter 291, Subchapter
C (§§291.51 - 291.55), concerning Nuclear Pharmacy (Class B), pursuant
to the Texas Government Code, §2001.039, regarding Agency Review of Existing
Rules. The proposed review was published in the December 2, 2005, issue of
the
Texas Register
(30 TexReg 8183).
No comments were received.
The agency finds the reason for adopting the rules continues to exist.
TRD-200600779
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Filed: February 14, 2006
The Texas State Board of Pharmacy adopts the review of Chapter 305 (§305.1
and §305.2), concerning Educational Requirements, pursuant to the Texas
Government Code, §2001.039, regarding Agency Review of Existing Rules.
The proposed review was published in the December 2, 2005, issue of the
No comments were received.
The agency finds the reason for adopting the rules continues to exist.
TRD-200600777
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Filed: February 14, 2006
The Texas State Board of Pharmacy (Board) adopts the review of Chapter
309 (§309.1 and §309.8), concerning Generic Substitution, pursuant
to the Texas Government Code, §2001.039, regarding Agency Review of Existing
Rules. The proposed review was published in the December 2, 2005, issue of
the
Texas Register
(30 TexReg 8183).
The Board received written comments from the following: Abbott Laboratories,
Inc.; American Thyroid Association; The Thyroid Foundation of America, Inc.;
American Association of Clinical Endocrinologists; Richard Berger, M.D.; Lance
Sloan, M.D.; Robert Talbert, Pharm. D., FCCP, BCPS, Division of Pharmacotherapy,
College of Pharmacy, The University of Texas; Keith L Parker, M.D., Ph.D.,
Chief of Endocrinology and Metabolism, Southwestern Medical Center; Simona
Scumpia, M.D., FACE, FRCP; and Kay R. Lewis, M.D., University of Texas Health
Science Center at Houston. The written comments submitted recommended that
the Board amend §309.3(e)(2) to include levothyroxine sodium as a narrow
therapeutic index drug. The Board took no action based on the written comments.
The agency finds the reason for adopting the rules continues to exist.
TRD-200600778
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Filed: February 14, 2006
Adopted Rule Reviews
Texas State Board of Pharmacy